tradingkey.logo
tradingkey.logo
Search

60 Degrees Pharmaceuticals Inc

SXTP
Add to Watchlist
1.490USD
-0.080-5.10%
Market hours ETQuotes delayed by 15 min
3.93MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Kathmere Capital Management
5.49%
Orca Capital GmbH
1.58%
UBS Financial Services, Inc.
1.19%
Dow (Geoffrey S)
0.64%
Knight Therapeutics, Inc.
0.32%
Other
90.79%
Shareholders
Shareholders
Proportion
Kathmere Capital Management
5.49%
Orca Capital GmbH
1.58%
UBS Financial Services, Inc.
1.19%
Dow (Geoffrey S)
0.64%
Knight Therapeutics, Inc.
0.32%
Other
90.79%
Shareholder Types
Shareholders
Proportion
Investment Advisor
8.27%
Individual Investor
0.89%
Corporation
0.32%
Research Firm
0.21%
Investment Advisor/Hedge Fund
0.12%
Hedge Fund
0.06%
Other
90.13%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
27
228.38K
8.66%
+141.57K
2025Q4
25
52.23K
4.06%
-28.54K
2025Q3
22
451.55K
11.00%
+385.44K
2025Q2
28
103.95K
3.22%
+2.41K
2025Q1
28
93.99K
6.38%
-12.96K
2024Q4
26
104.62K
14.10%
+11.58K
2024Q3
25
101.03K
25.05%
+54.30K
2024Q2
23
54.29K
27.13%
-3.10K
2024Q1
19
57.35K
31.08%
+1.78K
2023Q4
19
60.17K
63.69%
+30.80K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Orca Capital GmbH
41.56K
1.58%
+41.56K
--
Jul 16, 2025
Dow (Geoffrey S)
11.36K
0.43%
+5.66K
+99.32%
Dec 15, 2025
Knight Therapeutics, Inc.
8.47K
0.32%
+3.67K
+76.27%
Sep 30, 2024
Xu (Cheryl)
3.95K
0.15%
+1.75K
+79.40%
Aug 26, 2025
Geode Capital Management, L.L.C.
3.11K
0.12%
--
--
Dec 31, 2025
Tower Research Capital LLC
1.69K
0.06%
+900.00
+114.65%
Dec 31, 2025
Miller (Tyrone)
1.32K
0.05%
--
--
Aug 26, 2025
Landon (Kristen)
1.14K
0.04%
--
--
Aug 26, 2025
View more
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.